Order Article Reprints

Zhang C, Guo S, Zhong Q, Zhang Q, Hossain A, Zheng S, Wang G. Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability. Pharmaceuticals. 2019; 12(4):180. https://doi.org/10.3390/ph12040180

Zhang, Changde, Shanchun Guo, Qiu Zhong, Qiang Zhang, Ahamed Hossain, Shilong Zheng, and Guangdi Wang. 2019. "Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability" Pharmaceuticals 12, no. 4: 180. https://doi.org/10.3390/ph12040180

Zhang, C., Guo, S., Zhong, Q., Zhang, Q., Hossain, A., Zheng, S., & Wang, G. (2019). Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability. Pharmaceuticals, 12(4), 180. https://doi.org/10.3390/ph12040180